Orange Grove Bio (OGB) is a preclinical drug investment and development platform.
Orange Grove Bio has raised $5.1M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in April 2024.
Orange Grove Bio's investors include Small Business Innovation Research, THE CATALYTIC IMPACT FOUNDATION (CIF).
Orange Grove Bio is headquartered in Cincinnati, United States.
Orange Grove Bio (OGB) is a preclinical drug investment and development platform.
Orange Grove Bio is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Orange Grove Bio — Funding & Investors." VCBacked, April 24, 2024, https://www.vcbacked.co/company/orange-grove-bio. Accessed August 14, 2026.
VCBacked. (2024). Orange Grove Bio — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/orange-grove-bio
{{cite web |title=Orange Grove Bio — Funding & Investors |url=https://www.vcbacked.co/company/orange-grove-bio |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated